An Ensemble Model for Prediction of Vancomycin Trough Concentrations in Pediatric Patients

Xiaohui Huang1, Ze Yu2, Shuhong Bu1

  • 1Department of Pharmacy, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

Insights

Machine learning models effectively predict vancomycin trough concentrations in pediatric patients. An ensemble model demonstrated superior accuracy compared to traditional pharmacokinetic methods, improving therapeutic drug monitoring.

Area of Science:

  • Pharmacology
  • Machine Learning
  • Pediatric Medicine

Background:

  • Vancomycin is crucial for treating serious infections, but requires careful dosing to maintain therapeutic levels and minimize toxicity.
  • Predicting vancomycin trough concentrations is challenging due to patient variability, especially in pediatric populations.

Purpose of the Study:

  • To develop and optimize a machine learning model for predicting vancomycin trough concentrations in pediatric patients.
  • To compare the predictive performance of various machine learning algorithms.

Main Methods:

  • Utilized data from 407 pediatric patients receiving intravenous vancomycin.
  • Compared eight machine learning algorithms, including XGBoost, GBRT, Bagging, ExtraTree, and decision trees.
  • Ensembled top-performing algorithms to create a final predictive model.

Main Results:

  • The final ensemble model achieved an R-squared of 0.614, MAE of 3.32, and RMSE of 4.94.
  • Prediction accuracy was 51.22% within ±30% of actual trough concentrations.
  • The machine learning model significantly outperformed traditional pharmacokinetic models (R-squared = 0.3).

Conclusions:

  • An ensemble machine learning model provides a valuable tool for predicting vancomycin trough concentrations in children.
  • This approach offers improved accuracy and clinical utility, particularly for pediatric patients with high inter-individual variability.
  • Further advancements in machine learning are expected to enhance the clinical application of such predictive models.
Abstract

Related Concept Videos

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
52
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
71
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
54
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
90
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
603